Amphenol (APH) official guidance
Amphenol (APH) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.
See the full Filings Intelligence suiteAPHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
1 metric1 maintainedearnings call · 1d
2026-10-28 18:47:09 UTC$2.82 – $2.84maintained
Our fourth quarter guidance represents also an expectation for full-year sales of $36.9 billion to $37.1 billion and full-year adjusted diluted EPS of $2.82 to $2.84.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$2.82 – $2.84new
For the full year 2026, Amphenol expects sales to be in the range of $36.9 billion to $37.1 billion, representing an approximately 60% increase over prior year, while Adjusted Diluted EPS is expected to be in the range of $2.82 to $2.84, representing an approximately 70% increase over prior year.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 maintainedearnings call · 1d
2026-10-28 18:47:09 UTC$0.81 – $0.83maintained
Turning to our outlook, and obviously assuming the continuation of current market conditions as well as constant exchange rates, for the fourth quarter, we expect sales in the range of $10.3 billion to $10.5 billion, and adjusted diluted EPS in the range of $0.81 to $0.83.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$0.81 – $0.83new
Adjusted Diluted EPS is expected to be in the range of $0.81 to $0.83, representing a 65% to 69% increase from the fourth quarter of 2025.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
3 metrics3 maintainedearnings call · 1d
2026-10-28 18:47:09 UTC$0.18maintained
We now expect CommScope to achieve $5.1 billion in sales and to contribute $0.18 to our 2026 adjusted earnings per share.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$0.18lowered -40.0%
In addition, given the continued better-than-expected performance of the CommScope business, Amphenol now expects the business to generate full-year sales of $5.1 billion and to be $0.18 accretive to the Company’s Adjusted Diluted EPS in 2026 which is reflected in our outlook.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-07-29 14:27:32 UTC$0.3raised +100.0%
In addition, given the better than expected performance of CommScope, Amphenol now expects this acquisition to generate full-year sales of $4.6 billion and to be $0.30 accretive to the Company’s Adjusted Diluted EPS in 2026.
APH · EX-99.1 · Q2 FY2026
2026-07-29 14:26:52 UTCOpen source
2026-04-30 04:01:09 UTC$0.15maintained
And we continue to expect the company to deliver this year, as we said, you know, roughly $4.1 billion in sales and $0.15 of accretion.
APH · transcript · Q1 FY2026
2026-04-30 04:00:00 UTCOpen source
2026-01-28 14:25:43 UTC$0.15new
As previously disclosed, Amphenol expects the CCS business to generate full-year 2026 sales of approximately $4.1 billion and add approximately $0.15 to Amphenol’s 2026 Adjusted Diluted EPS.
APH · EX-99.1 · Q4 FY2025
2026-01-28 14:24:47 UTCOpen source
2026-10-28 18:47:09 UTC$270Mmaintained
First, AdvancedPCB is a U.S.-based manufacturer of high-technology printed circuit boards for the defense and industrial markets. The company is headquartered in Colorado and expects full year sales of approximately $270 million this year.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$270Mnew
Headquartered in Colorado, AdvancedPCB is expected to have full-year 2026 sales of approximately $270 million and will be included in the Harsh Environment Solutions segment post-closing.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-10-28 18:47:09 UTC$5.1Bmaintained
We now expect CommScope to achieve $5.1 billion in sales and to contribute $0.18 to our 2026 adjusted earnings per share.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$5.1Braised +10.9%
In addition, given the continued better-than-expected performance of the CommScope business, Amphenol now expects the business to generate full-year sales of $5.1 billion and to be $0.18 accretive to the Company’s Adjusted Diluted EPS in 2026 which is reflected in our outlook.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-07-30 04:01:10 UTC$4.6Bmaintained
Indeed, we now expect CommScope to deliver $4.6 billion of sales and $0.30 of accretion for the full-year of 2026, and this represents a significant upgrade from our previous expectations of $4.1 billion and $0.15.
APH · transcript · Q2 FY2026
2026-07-30 04:00:00 UTCOpen source
2026-07-29 14:27:32 UTC$4.6Braised +12.2%
In addition, given the better than expected performance of CommScope, Amphenol now expects this acquisition to generate full-year sales of $4.6 billion and to be $0.30 accretive to the Company’s Adjusted Diluted EPS in 2026.
APH · EX-99.1 · Q2 FY2026
2026-07-29 14:26:52 UTCOpen source
2026-04-30 04:01:09 UTC$4.1Bmaintained
And we continue to expect the company to deliver this year, as we said, you know, roughly $4.1 billion in sales and $0.15 of accretion.
APH · transcript · Q1 FY2026
2026-04-30 04:00:00 UTCOpen source
2026-01-28 14:25:43 UTC$4.1Bnew
As previously disclosed, Amphenol expects the CCS business to generate full-year 2026 sales of approximately $4.1 billion and add approximately $0.15 to Amphenol’s 2026 Adjusted Diluted EPS.
APH · EX-99.1 · Q4 FY2025
2026-01-28 14:24:47 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCremain at these strong third quarter levelsnew
Looking into the fourth quarter, we expect sales to remain at these strong third quarter levels.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
4 metrics4 maintainedearnings call · 1d
2026-10-28 18:47:09 UTC$90Mmaintained
With approximately 100 employees, Dexgreen is expected to generate full year 2026 sales of approximately $90 million and will be included in the communication solutions segment post-closing.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$90Mnew
Headquartered in Ireland, Dexgreen is expected to generate full-year 2026 sales of approximately $90 million and will be included in the Communications Solutions segment post-closing.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-10-28 18:47:09 UTC$320Mmaintained
First, we closed on the acquisition of Empire Electronics at the beginning of September, with 2026 full year revenue expected to reach approximately $320 million.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$320Mnew
Headquartered in Michigan, Empire Electronics is expected to generate full-year 2026 sales of approximately $320 million.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-10-28 18:47:09 UTC$70Mmaintained
The company has approximately 350 employees and expects full year 2026 sales of approximately $70 million.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$70Mnew
Humanetics Sensors is expected to generate full-year 2026 sales of approximately $70 million and will be included in the Interconnect and Sensor Systems segment post-closing.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
2026-10-28 18:47:09 UTC$36.9B – $37.1Bmaintained59.8% – 60.6% vs FY2025
Our fourth quarter guidance represents also an expectation for full-year sales of $36.9 billion to $37.1 billion and full-year adjusted diluted EPS of $2.82 to $2.84.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$36.9B – $37.1Bnew59.8% – 60.6% vs FY2025
For the full year 2026, Amphenol expects sales to be in the range of $36.9 billion to $37.1 billion, representing an approximately 60% increase over prior year, while Adjusted Diluted EPS is expected to be in the range of $2.82 to $2.84, representing an approximately 70% increase over prior year.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 maintainedearnings call · 1d
2026-10-28 18:47:09 UTC$10.3B – $10.5Bmaintained60% – 63.1% vs Q4 FY2025
Turning to our outlook, and obviously assuming the continuation of current market conditions as well as constant exchange rates, for the fourth quarter, we expect sales in the range of $10.3 billion to $10.5 billion, and adjusted diluted EPS in the range of $0.81 to $0.83.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 13:43:48 UTC$10.3B – $10.5Bnew60% – 63.1% vs Q4 FY2025
Assuming the continuation of current market conditions as well as constant exchange rates, for the fourth quarter of 2026, Amphenol expects sales to be in the range of $10.3 to $10.5 billion, representing an approximately 60% increase over the prior year quarter.
APH · EX-99.1 · Q3 FY2026
2026-10-28 13:42:41 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTC10%new10% vs FY2025
For the fourth quarter, we do expect a slight sales moderation from these third-quarter levels, and for the full year 2026, we anticipate that sales will increase in the 10% range from prior year.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCa slight sales moderation from these third-quarter levelsnew
For the fourth quarter, we do expect a slight sales moderation from these third-quarter levels, and for the full year 2026, we anticipate that sales will increase in the 10% range from prior year.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
3 metrics3 newearnings call · 1d
2026-10-28 18:47:09 UTCmore than double for the full year 2026new
Accordingly, we now expect CommScope sales in the IT datacom market to more than double for the full year 2026, and we expect that those sales should represent roughly half of their sales for the full year, and that compares to around a third of their sales last year.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 18:47:09 UTC20%new20% vs FY2025
For the full year 2026, we anticipate sales to increase by approximately 20%.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
2026-10-28 18:47:09 UTCat least 40%new40% vs FY2025
For the full year 2026, we expect sales growth of more than 40%, driven by the CommScope acquisition, partially offset by some organic decline.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCa further decline in sales from these third quarter levelsnew
Looking to the fourth quarter, we expect a further decline in sales from these third quarter levels on continued softness in spending, particularly in broadband.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCat least 35%new35% vs FY2025
For the full year of 2026, we anticipate sales to increase by more than 35%, primarily driven by strong organic growth as well as the benefit of acquisitions.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/Q4 FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCa mid-single-digit increase in salesnew
As we head into the fourth quarter, we expect a mid-single-digit increase in sales from these third quarter levels.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source
APHAMPHENOL CORP /DE/FY2026 · ends 2026-12-31
1 metric1 newearnings call · 1d
2026-10-28 18:47:09 UTCat least 50%new50% vs FY2025
For the full year 2026, we now expect sales growth of more than 50%, reflecting both strong organic growth as well as the benefit of acquisitions.
APH · transcript · Q3 FY2026
2026-10-28 18:46:00 UTCOpen source